首页> 外文期刊>Scandinavian journal of gastroenterology. >A patient with myelofibrosis complicated by refractory ascites and portal hypertension: to tips or not to tips? A case report with discussion of the mechanism of ascites formation.
【24h】

A patient with myelofibrosis complicated by refractory ascites and portal hypertension: to tips or not to tips? A case report with discussion of the mechanism of ascites formation.

机译:骨髓纤维化并发顽固性腹水和门静脉高压症的患者:提示还是不提示?一起讨论腹水形成机理的病例报告。

获取原文
获取原文并翻译 | 示例
           

摘要

In patients with myelofibrosis, clinically significant portal hypertension is known to be predominantly presinusoidal; however, the exact mechanisms are still controversial. The pathophysiology is particularly enigmatic in those patients without histological and angiographic evidence of significant intra- or extrahepatic obstruction to portal blood flow, respectively. Moreover, ascites formation has been reported in such cases, but in general is rare in presinusoidal portal hypertension. Here we present such a patient in which ascites developed even in the presence of unchanged serum protein levels (oncotic pressure) and was refractory to sodium restricted diet and high-dose diuretic treatment. A discussion on the parameters influencing fluid exchange and ascites formation particularly emphasizing the potential importance of the hyperdynamic circulation in this case is given. Finally, the patient was treated by implanting a transjugular intrahepatic shunt (TIPS), exerting a diuretic effect sufficient enough to avoid re-formation of ascites for several months. However, ascites re-accumulated potentially due to the appearance of ectopic peritoneal myeloid metaplasia and the patient died soon afterwards. In conclusion, TIPS may be considered as rescue management for refractory ascites secondary to portal hypertension, but caution in respect to the presence and/or development of peritoneal or other ectopic haematopoesis has to be taken.
机译:在患有骨髓纤维化的患者中,已知临床上显着的门脉高压主要是鼻窦窦前。但是,确切的机制仍存在争议。在没有组织学和血管造影证据分别显着肝内或肝外阻塞门脉血流的患者中,病理生理学尤其难以理解。此外,在这种情况下已有腹水形成的报道,但在前鼻窦前门静脉高压症中很少见。在这里,我们介绍了这样一种患者,即使在血清蛋白水平不变(血浆渗透压)不变的情况下,腹水也会出现,并且对钠限制饮食和大剂量利尿剂治疗无效。讨论了影响流体交换和腹水形成的参数,尤其强调了这种情况下高动力循环的潜在重要性。最后,通过植入经颈颈肝内分流术(TIPS)对患者进行治疗,其利尿作用足以避免腹水形成几个月。然而,由于异位腹膜髓质化生的出现,腹水可能会再次积聚,患者不久后死亡。总之,TIPS可以被认为是门静脉高压继发性难治性腹水的抢救措施,但必须注意腹膜或其他异位造血功能的存在和/或发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号